We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+14.29%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$960M
AUM Growth
+$115M
Cap. Flow
+$4.48M
Cap. Flow %
0.47%
Top 10 Hldgs %
31.03%
Holding
175
New
10
Increased
50
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
BLKB icon
Blackbaud
BLKB
+$882K
2
ABB
ABB Ltd
ABB
+$692K
3
CTSH icon
Cognizant
CTSH
+$544K
4
ALB icon
Albemarle
ALB
+$479K
5
TRMB icon
Trimble
TRMB
+$471K

Sector Composition

Rank Sector Weight
1 Technology 24.95%
2 Healthcare 17.82%
3 Financials 11.43%
4 Consumer Staples 11.05%
5 Industrials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
101
Intuitive Surgical
ISRG
$130B
$882K 0.09%
4,638
SGEN
102
DELISTED
Seagen Inc. Common Stock
SGEN
$839K 0.09%
11,460
+145
+1% +$10.3K
LLY icon
103
Eli Lilly
LLY
$1.09T
$795K 0.08%
6,125
-300
-5% -$36.5K
BA icon
104
Boeing
BA
$175B
$772K 0.08%
2,023
-400
-17% -$154K
BMY icon
105
Bristol-Myers Squibb
BMY
$130B
$747K 0.08%
15,651
V icon
106
Visa
V
$697B
$740K 0.08%
4,740
VV icon
107
Vanguard Large-Cap ETF
VV
$52B
$712K 0.07%
5,485
INCY icon
108
Incyte
INCY
$26B
$709K 0.07%
8,243
+106
+1% +$8.63K
GLD icon
109
SPDR Gold Trust
GLD
$131B
$699K 0.07%
5,727
RDS.A
110
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$695K 0.07%
11,098
+20
+0.2% +$1.24K
NBIX icon
111
Neurocrine Biosciences
NBIX
$18.4B
$694K 0.07%
7,881
+61
+0.8% +$5.1K
SCHW
112
Charles Schwab
SCHW
$184B
$688K 0.07%
16,092
CSX icon
113
CSX Corp
CSX
$94.2B
$681K 0.07%
27,300
FISV
114
Fiserv Inc
FISV
$28.9B
$644K 0.07%
7,296
+248
+4% +$20.5K
VEU icon
115
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$640K 0.07%
12,770
BMRN icon
116
BioMarin Pharmaceuticals
BMRN
$12B
$610K 0.06%
6,868
+112
+2% +$10.4K
MO icon
117
Altria Group
MO
$125B
$607K 0.06%
10,572
WAT icon
118
Waters Corp
WAT
$37.7B
$604K 0.06%
2,400
FUL icon
119
H.B. Fuller
FUL
$3.07B
$588K 0.06%
12,094
AMZN icon
120
Amazon
AMZN
$2.48T
$586K 0.06%
6,580
MCD icon
121
McDonald's
MCD
$194B
$570K 0.06%
3,004
J icon
122
Jacobs Solutions
J
$16.6B
$568K 0.06%
9,134
NBL
123
DELISTED
Noble Energy, Inc.
NBL
$563K 0.06%
22,749
NEE icon
124
NextEra Energy
NEE
$186B
$550K 0.06%
11,380
ALXN
125
DELISTED
Alexion Pharmaceuticals
ALXN
$545K 0.06%
4,028
+72
+2% +$8.95K

Similar funds

Grandfield & Dodd's Q1 2019 Portfolio in Review

As of Q1 2019, Grandfield & Dodd held 175 positions worth $960M, up 14% from $845M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd's Q1 2019 filing shows 10 new, 50 increased, 39 reduced and 2 closed positions. Its largest new stake was Blackbaud: 12,020 shares worth $958K. The largest sale was Chevron, an estimated $786K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q1 2019 buy was Blackbaud: 12,020 shares worth $958K.
  • Grandfield & Dodd added most to ABB Ltd in Q1 2019, an estimated $692K increase.
  • Grandfield & Dodd's biggest Q1 2019 reduction was Chevron, cutting an estimated $786K.
  • Grandfield & Dodd fully exited Pope Resources Depositary Receipts of Limited Partnership Units in Q1 2019, selling an estimated $360K.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $960M portfolio in Q1 2019.
  • Grandfield & Dodd opened 10 new positions and closed 2 in Q1 2019.
  • Grandfield & Dodd's portfolio value rose 14% quarter-over-quarter to $960M.

Based on Grandfield & Dodd's 13F filing for Q1 2019, filed 26 Apr 2019.